Atopic dermatitis (AD) is a chronic disease that affects an increasing number of children and adults. The skin is dry and ...

INDICATIONS ZORYVE cream, 0.05%, is indicated for topical treatment of mild to moderate atopic dermatitis in pediatric patients 2 to 5 years of age. ZORYVE cream, 0.15%, is indicated for topical ...

Sanofi has announced that its amlitelimab has shown positive results in the treatment of patients 12 years and older with atopic dermatitis (AD).

To test whether families unlinked to this major locus showed evidence for linkage elsewhere in the genome, we carried out an additional analysis in which weights 0 or 1 were assigned to each family ...

With shares down more than 40% since November, the risk-reward for Nektar Therapeutics has shifted ahead of pivotal clinical ...

Both children and adults with atopic dermatitis have an increased risk of inflammatory bowel disease (IBD), according to a population-based cohort study. In fully adjusted models, kids with atopic ...

Elaine Siegfried, MD: Are the terms atopic dermatitis and eczema interchangeable? They are, they are synonyms, except for atopic dermatitis is a very specific kind of eczema. Eczema and dermatitis are ...

Patients with atopic dermatitis (AD) report a desire for climate-health education, which is infrequently addressed by ...

A new study published in the journal of Pediatric Dermatology revealed that treatment with dupilumab achieved effective ...

DelveInsight’s 'Atopic Dermatitis Pipeline Insight – 2022' report provides comprehensive global coverage of available, marketed, and pipeline atopic dermatitis therapies in various stages of clinical ...

Amgen ends its rocatinlimab partnership, returning control to Kyowa Kirin, citing strategy changes, weaker Phase 3 results ...

Dublin, July 23, 2025 (GLOBE NEWSWIRE) -- The "Atopic Dermatitis Market Report and Forecast 2025-2034" report has been added to ResearchAndMarkets.com's offering. The atopic dermatitis market attained ...